Icon (ICLR) Accounts Payables (2009 - 2026)
Icon's (ICLR) quarterly Accounts Payables came in at $118.2 million in Q2 2026, up 25.12% year-over-year from $94.5 million in Q2 2025, and up 18.42% quarter-over-quarter from $99.8 million in Q1 2026.
Analysis
Icon (ICLR) Accounts Payables (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Accounts Payables for 18 consecutive years, with $118.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accounts Payables rose 25.12% year-over-year to $118.2 million in Q2 2026; TTM through Jun 2026 was $118.2 million, a 25.12% increase from a year earlier, with the FY2025 full-year figure at $192.1 million, up 11.03% from the prior year.
- Accounts Payables was $118.2 million for Q2 2026 at Icon, up from $99.8 million in the prior quarter.
- Over five years, Accounts Payables peaked at $192.1 million in Q4 2025 and troughed at $46.9 million in Q2 2023.
- A 5-year average of $102.6 million and a median of $97.2 million in 2025 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 105.32% in 2022 and tumbled 39.57% in 2023, its largest moves.
- Over 5 years, Accounts Payables stood at $81.2 million in 2022, then surged by 62.06% to $131.6 million in 2023, then soared by 31.49% to $173.0 million in 2024, then gained by 11.03% to $192.1 million in 2025, then sank by 38.46% to $118.2 million in 2026.
- The last three Accounts Payables figures came in at $118.2 million (Q2 2026), $99.8 million (Q1 2026), and $192.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 37.53 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 118.24 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 140.98 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 54.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 57.10 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 9.58 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 5.63 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 3.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.24 Mn |
| Mar 31, 2026 | 99.85 Mn |
| Dec 31, 2025 | 192.12 Mn |
| Sep 30, 2025 | 113.29 Mn |
| Jun 30, 2025 | 94.50 Mn |
| Mar 31, 2025 | 118.17 Mn |
| Dec 31, 2024 | 173.03 Mn |
| Sep 30, 2024 | 106.17 Mn |
| Jun 30, 2024 | 83.04 Mn |
| Mar 31, 2024 | 113.58 Mn |
| Dec 31, 2023 | 131.58 Mn |
| Sep 30, 2023 | 87.32 Mn |
| Jun 30, 2023 | 46.92 Mn |
| Mar 31, 2023 | 85.13 Mn |
| Dec 31, 2022 | 81.19 Mn |
| Sep 30, 2022 | 60.85 Mn |
| Jun 30, 2022 | 77.65 Mn |
| Mar 31, 2022 | 63.51 Mn |
| Dec 31, 2021 | 90.76 Mn |
| Sep 30, 2021 | 62.58 Mn |